Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


18.09.2017

1 Cancer
1 Cancer Lett
3 Cancer Res
1 J Clin Invest
3 J Invest Dermatol
3 N Engl J Med
2 Nat Med
1 PLoS Genet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cancer

  1. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. KLIMKIEWICZ K, Weglarczyk K, Collet G, Paprocka M, et al
    A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection.
    Cancer Lett. 2017;396:10-20.
    PubMed     Text format     Abstract available


    Cancer Res

  3. NDOYE A, Budina-Kolomets A, Kugel CH, Webster MR, et al
    ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma.
    Cancer Res. 2017 Sep 8. pii: canres.0907.2017.
    PubMed     Text format     Abstract available

  4. LARIMER BM, Wehrenberg-Klee E, Dubois F, Mehta A, et al
    Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.
    Cancer Res. 2017;77:2318-2327.
    PubMed     Text format     Abstract available

  5. GUO G, Yu M, Xiao W, Celis E, et al
    Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.
    Cancer Res. 2017;77:2292-2305.
    PubMed     Text format     Abstract available


    J Clin Invest

  6. ANSA-ADDO EA, Zhang Y, Yang Y, Hussey GS, et al
    Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-beta signaling.
    J Clin Invest. 2017;127:1321-1337.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  7. SEO EY, Jin SP, Sohn KC, Park CH, et al
    UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
    J Invest Dermatol. 2017 Apr 6. pii: S0022-202X(17)31396.
    PubMed     Text format     Abstract available

  8. YU B, Alboslemy T, Safadi F, Kim MH, et al
    Glycoprotein non-melanoma clone B regulates the crosstalk between macrophages and mesenchymal stem cells towards wound repair.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32934.
    PubMed     Text format     Abstract available

  9. HAO J, Xu H, Luo M, Yu W, et al
    The tumor-promoting role of TRIP4 in melanoma progression and its involvement in response to BRAF-targeted therapy.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32937.
    PubMed     Text format     Abstract available


    N Engl J Med

  10. WEBER J, Mandala M, Del Vecchio M, Gogas HJ, et al
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.
    PubMed     Text format     Abstract available

  11. LONG GV, Hauschild A, Santinami M, Atkinson V, et al
    Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1708539.
    PubMed     Text format     Abstract available

  12. WOLCHOK JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.
    PubMed     Text format     Abstract available


    Nat Med

  13. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available

  14. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available


    PLoS Genet

  15. CAIRNEY CJ, Godwin LS, Bilsland AE, Burns S, et al
    A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.
    PLoS Genet. 2017;13:e1006942.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: